Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells
- PMID: 16916581
- DOI: 10.1016/j.neulet.2006.06.072
Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells
Abstract
Presenilin-1 gene mutations have been proven to be associated with the majority of early-onset familial Alzheimer's disease (FAD). There have been, however, no systematic studies of Presenilin-1 gene mutation in FAD in China so far. We found a novel Val-->Leu missense mutation at codon 97 (Val97Leu) of the Presenilin-1 gene in a Chinese FAD pedigree. To verify whether this mutation is pathologically functional, we established mutation type and wild type Presenilin-1 gene stably transfected cell lines (human neuroblastoma SH-SY5Y cells) to detect beta-amyloid (Abeta) concentrations using ELISA and radioimmunity methods. We also examined levels of beta-amyloid precursor protein cleaving enzyme (BACE) and amyloid precursor protein (APP) to explore their impact upon beta-amyloid production. Our results showed that Abeta42 concentration was significantly enhanced at 48h when compared to that at 24h in the mutant type cells. At 48h Abeta42 levels in the V97L mutants was also found to be elevated significantly, both intracellularly and extracellularly when compared to wild and mock transfected cells. The total Abeta in either group did not alter, consistent with unchanged BACE and APP expression levels. Our data reveal that the Presenilin-1 V97L variant can elevate Abeta42 levels both intracellularly and extracellularly, and was a potentially pathogenic mutation for this Chinese FAD pedigree. It also suggests that there are common mechanisms in the pathogenesis of FAD between Chinese and other ethnic populations, although their gene mutation sites are different.
Similar articles
-
Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells.J Neurochem. 2004 Dec;91(6):1260-74. doi: 10.1111/j.1471-4159.2004.02816.x. J Neurochem. 2004. PMID: 15584903
-
Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2.Eur J Neurosci. 2004 Jan;19(2):258-264. doi: 10.1111/j.0953-816x.2003.03135.x. Eur J Neurosci. 2004. PMID: 14725619
-
Effect of protein kinase A inhibitors on the production of Abeta40 and Abeta42 by human cells expressing normal and Alzheimer's disease-linked mutated betaAPP and presenilin 1.Br J Pharmacol. 1999 Mar;126(5):1186-90. doi: 10.1038/sj.bjp.0702406. Br J Pharmacol. 1999. PMID: 10205007 Free PMC article.
-
Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. doi: 10.1007/s004060050098. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10653281 Review.
-
Intracellular biology of Alzheimer's disease amyloid beta peptide.Eur Arch Psychiatry Clin Neurosci. 1999;249(6):291-8. doi: 10.1007/s004060050102. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10653285 Review.
Cited by
-
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.J Adv Res. 2022 Sep;40:207-221. doi: 10.1016/j.jare.2021.07.001. Epub 2021 Jul 6. J Adv Res. 2022. PMID: 36100328 Free PMC article. Review.
-
Application of CRISPR/Cas9 in Alzheimer's Disease.Front Neurosci. 2021 Dec 21;15:803894. doi: 10.3389/fnins.2021.803894. eCollection 2021. Front Neurosci. 2021. PMID: 34992519 Free PMC article. Review.
-
Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.Clin Interv Aging. 2018 Feb 7;13:221-233. doi: 10.2147/CIA.S155145. eCollection 2018. Clin Interv Aging. 2018. PMID: 29445268 Free PMC article. Review.
-
The genetics of Alzheimer's disease.Clin Interv Aging. 2014 Apr 1;9:535-51. doi: 10.2147/CIA.S51571. eCollection 2014. Clin Interv Aging. 2014. PMID: 24729694 Free PMC article. Review.
-
The Genetics of Alzheimer's Disease in the Chinese Population.Int J Mol Sci. 2020 Mar 30;21(7):2381. doi: 10.3390/ijms21072381. Int J Mol Sci. 2020. PMID: 32235595 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases